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Group B streptococcus (GBS) neonatal invasive infect ions in Belgium
2010-2017, and characterization of isolated strains. 
RATIONALE & OBJECTIVES 
Where intrapartum antibiotic-prophylaxis (IAP) is given to
pregnant women colonized with Group B Streptococcus
(GBS), the incidence of neonatal early-onset disease (EOD)
has been successfully reduced. Nevertheless, GBS is still the
leading cause of severe disease among newborns, notably
because the incidence of GBS late-onset disease (LOD) is not
affected by IAP. Another strategy such as maternal
immunization for prevention of both EOD/LOD is highly
desirable worldwide.
The Belgian National Reference Centre (NRC) routinely
performs surveillances of GBS invasive strains.
This study refers to GBS neonatal invasive diseases, EOD
and LOD cases, reported to the Belgian NRC from 2010
up to 2017.
To describe epidemiology of GBS isolated from neonatal
EOD or LOD cases by characterization of relevant
epidemiological markers for vaccine development and
their distribution:
- Capsular polysaccharide (CPS) type
In Belgium, GBS invasive infection is not a reportable disease; but a regular surveillance of diseases and characterization of GBS isolates is 
performed by the Belgian National Reference Centre (NRC) for Streptococcus agalactiae (GBS).
STUDY POPULATION AND METHODS
Population:
• Overall through years 2010 to 2017, on a voluntary base, laboratories belonging to the national sentinel network sent to the NRC a total
of 292 strains of GBS isolated from bloodculture or cerebro-spinal fluid of newborns with invasive disease. They were issued from 149
EOD (0-6days) and 143 LOD (1 week-3 months).
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Identification and CPS Typing (types Ia, Ib, II to IX)
• Identification, upon reception of isolates, GBS identification 
was confirmed (MALDI-TOF mass spectrometry, Bruker) and 
strains were stored at -80°C.
• Serotyping, Latex agglutination (Strep B Latex, Statens Serum 
Institut, Denmark)
• Genotyping, PCR.
• Multiplex PCR, Types Ia, Ib, II to VIII, Poyart, C. et al. 2007 J. 
Clin. Microbiol. 45, 1985–8
Pilus island characterization (PI-1, PI-2a & PI-2b) 
• Multiplex PCR  (Springman, AC. et al.
2014 BMC Microbiol. 19;14:159 )
Multiple-Locus Sequence-Typing (MLST)
• Seven housekeeping genes (adhP, pheS, atr, glnA, sdhA, glcK, 
and tkt) were amplified and sequenced as described by Jones 
et al, 2003, J. Clin. Microbiol. 41, 2530-6
• The STs were determined by the S.agalactiae MLST website 
Distribution of CPS types among GBS isolated from neonatal E OD and LOD
- Pilus island (PI) pattern
- Multi-Locus Sequence-Type (MLST)
Distribution of STs among GBS isolated from neonatal
EOD and LOD (2016 – 2017)
RESULTS
Figure 2: Biennial distribution of CPS types of 292 GBS strains isolated from newborns with invasive
disease.
• The most prevalent CPS type was III either
among EOD cases (39%) or LOD cases (75%),
followed mainly by types Ia, V and II for EOD and
type Ia for LOD. (Fig. 1 & 2)
• These distributions did not vary significantly
during the study period. (Fig.2)
Distribution of pilus island patterns among GBS isolated
from neonatal EOD and LOD (2014-2017)














































Ia Ib II III IV V OthersFigure 1: Distribution of CPS types of 292 GBS
strains isolated from newborns with
















Figure 3: Distribution of pilus island patterns of 169 GBS strains
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• All GBS strains harbored at least one PI gene, singly or
Figure 5: Distribution of ST of 96 GBS strains isolated from newborns with
invasive disease, EOD or LOD.
Figure 6: Distribution of the 6 most
represented ST within the different CPS types.
• The strains were classified into 18 individual sequence
 CPS type III predominated in neonatal infections, EOD and LOD ; CPS type 
Ia, II and V were 2nd and 3rd rank for EOD.
 The reported distribution of CPS types of GBS isolated from neonatal 
EOD/LOD did not vary significantly overtime when compared to the Belgian 
reported data concerning GBS isolated from neonatal invasive diseases 
during the previous decade 1998-2007. (Fig.8)
 This distribution of CPS types was also consistent with reported European 
data. (Fig.8)
 One or two pilus island genes were detected in all strains of GBS (except 
one isolate).
 PI genes were not evenly distributed within CPS types: PI-2b singly or in 
combination demonstrated a correlation with type III, and PI-2a singly was 
mainly found in CPS type Ia.
 Strains of CPS type III were mainly represented by the hypervirulent GBS 
ST-17 (85%) ; and, GBS ST-17 were only found in CPS type III.
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Figure 8: Distribution of CPS types of 292 GBS strains isolated from newborns with invasive disease in
Belgium (2010-2017) compared to 301 GBS isolated previously in Belgium (1998-2007), 438 GBS in
France through 2007-2012 (39.7% EOD and 60.3% of LOD)1 and 159 GBS from 8 European countries
participating in the DEVANI Project (EU FP7) 2009-2011 (52.9% EOD and 47.1% LOD)2.
1- Joubrel et al, 2015, Clin Microbiol Infect 21:510-6
2- Melin, DEVANI Consortium team et al. EU-Framework Program Seven, XVIII LISSSD September 2011, Sicily
Figure 4: Distribution of pilus island
patterns among the different CPS types of 94
GBS strains isolated through 2016-2017
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in combination, except one isolate from EOD.
• With 64% harboring PI-2a and 35% PI-2b among GBS from
EOD, and 61%, harboring PI-2b and 39% PI-2a among
strains isolated from LOD. (Fig.3)
• The PI-2a singly is mainly found in CPS type Ia. (Fig.4)
• The PI-2b singly or in combination is mainly found in type
III. (Fig.4)
Figure 7: Serotype distribution within each
of the 6 most represented ST.
types.
• A high prevalence of ST-17 was detected : 35% of isolates
from EOD and 64% from LOD. (Fig.5)
• A strong correlation was shown between CPS type III and
ST-17, between CPS Ia and ST-23. (Fig.6 & 7)
• More diversity of STs was observed for CPS type V. (Fig.6 & 7)
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